Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Acquires Proxeon

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today announced that it has acquired proteomics tools firm Proxeon for an undisclosed sum.

The privately-held Danish firm makes nanoflow liquid chromatography systems, columns, ion sources, and bioinformatics software for liquid chromatography/mass spectrometry analysis in complex proteomics applications. Proxeon's primary product is its Easy-nLC nanoflow liquid chromatography system.

"By offering a high-performance solution that addresses the need for simplified operation, we can meet the increasing demand for LC/MS in proteomics applications," Thermo Fisher President and CEO Marc Casper said in a statement. "These systems can be easily integrated with our leading ion trap, hybrid and triple quadrupole mass spectrometry systems, in line with our strategy of providing comprehensive LC/MS solutions for both high-end research and routine applications."

Proxeon had 2009 revenues of around $10 million, according to Thermo Fisher. The firm, which employs approximately 40 people, will be integrated into Thermo Fisher's Analytical Technologies Segment.

Thermo Fisher said that it does not expect the purchase to have a material impact on its 2010 financial results.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.